Menu
Archives: HRS News
Johnson & Johnson Ordered to Pay $502 Million Following DePuy Pinnacle Hip Trial
Last week, a jury considering the bellwether cases of five patients implanted with DePuy Pinnacle artificial hip-replacement products found the company liable for medical bills and personal injuries caused by the defective devices. The jury arrived at a verdict of $502 million, which will be distributed among the five patients and healthcare payers involved. These … Read more
Federal Panel Creates Consolidated Action to Hear Levaquin Claims
On August 17, the Federal Judicial Panel on Multi-District Litigation created a consolidated action to hear legal claims against the makers of antibiotics Cipro, Avelox and Levaquin. The consolidated action (MDL No. 2642) will hear all claims related to fluoroquinolone antibiotics, including later claims filed against drug makers Bayer Pharmaceuticals (Cipro and Avelox), Janssen Pharmaceuticals … Read more
Court Upholds $4 Million Verdict Against Maker of Topamax
On August 20, a Pennsylvania Superior Court affirmed a $4 million dollar verdict against drug maker Janssen Pharmaceuticals, upholding claims related to Topamax, an anti-migraine and anti-convulsant medication. This suit is part of a larger mass tort consolidated in Philadelphia, in which plaintiffs allege that defendants including Janssen, a subsidiary of Johnson and Johnson, failed … Read more
Janssen Pharmaceuticals Faces More Trials Over Risperdal Side Effects
On August 17, two more Risperdal cases were given trial dates, following the trial of 3 earlier cases. These suits are part of a larger mass tort consolidated in Philadelphia, in which plaintiffs allege that defendants including Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, failed to provide adequate warnings that the anti-psychotic drug Risperdal … Read more
Drug Makers Announce $56.9 Settlement Fund for Yaz, Yasmin and Ocella Claims
Earlier this month, several drug companies announced the creation of a $56.9 million fund to resolve claims related to the popular Yaz, Yasmin, and Ocella birth control medications. The settlement follows allegations that the drug makers failed to warn doctors of specific known risks that taking these medications could cause a patient to develop dangerous blood … Read more
